Piramal Pharma's GHG Commitment Validated and Approved by SBTi
This validation aligns with Piramal Pharma's core purpose of 'Doing Well and Doing Good,'
This validation aligns with Piramal Pharma's core purpose of 'Doing Well and Doing Good,'
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
New Phase II data show vast majority of patients experiencing no relapses or disability progression
The inspection scope included 6 separate Biologics manufacturing units comprising 4 Drug Substance and 2 Drug Product manufacturing plants
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Accelerating sustainability in Indian pharma industry
Launch of 20 new medicines expected by 2030
Subscribe To Our Newsletter & Stay Updated